BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway
BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway is a paper indexed in ScholarIQ from OpenAlex.
How many citations does BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway have?
BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway has 142 citations in the OpenAlex counts ScholarIQ stores.
When was BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway published?
BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway has 2020 year in the ScholarIQ index.
What is the open-access status of BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway?
BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway has gold oa status in the ScholarIQ index.
What is the DOI of BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway?
The DOI for BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway is on the source record.
What is the PMID of BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway?
The PMID for BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway is on the source record.
What is the OpenAlex record for BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway?
The OpenAlex for BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway is on the source record.